Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07767487 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of LY4226695 in Healthy Participants

StatusNot Yet Recruiting
PhasePhase 1
Started2026-08
View on ClinicalTrials.gov ↗
The main purpose of this study is to assess how well LY4226695 is tolerated and what side effects may occur in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. For each participant in Parts A \& D, the study will last about 64 days and will include a stay in the Clinical Research Unit (CRU) lasting at most 7 days. For each participant in Parts B \& C, the study will last about 92 days and will include 5 stays in the CRU with each visit lasting at most 7 days.
Trial Details
NCT Number NCT07767487
Lead Sponsor Eli Lilly and Company
Conditions Healthy
Enrollment 148 participants
Start Date 2026-08
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-17